Results
1463
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
1,463 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GIG | NOK 29.60 | 0.2% | 6.5% | NOK 4.0b | NOK 45.03 | PE18.2x | E37.4% | n/a | Consumer Services | ||
KEBNI B | SEK 1.42 | -7.4% | 1.6% | SEK 384.5m | SEK 2.20 | PS4.2x | E90.4% | n/a | Tech | ||
EH | US$11.86 | -7.2% | -41.2% | US$750.6m | US$24.98 | PS34.2x | E74.3% | n/a | Capital Goods | ||
VOW | NOK 6.95 | -7.0% | -55.3% | NOK 791.2m | NOK 11.00 | PB2x | E97.7% | 0% | Commercial Services | ||
CRDO | US$25.33 | -7.5% | 54.4% | US$4.2b | US$32.17 | PS21.7x | E60.9% | n/a | Semiconductors | ||
CALTX | SEK 206.20 | 0% | 115.8% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
CUV | AU$13.67 | -7.3% | -22.4% | AU$735.1m | AU$30.33 | PE22.7x | E26.8% | 0.4% | Pharmaceuticals & Biotech | ||
4480 | JP¥3,215.00 | -23.1% | -36.0% | JP¥118.4b | JP¥5,800.00 | PE39x | E28.7% | n/a | Healthcare | ||
A067310 | ₩19,190.00 | 0.4% | -0.6% | ₩910.1b | ₩28,000.00 | PB3.1x | E97.4% | 0.3% | Semiconductors | ||
A178320 | ₩25,350.00 | -5.6% | 63.0% | ₩1.4t | ₩39,333.33 | PE131.9x | E58.7% | 0% | Tech | ||
A137400 | ₩52,500.00 | -3.1% | -24.5% | ₩1.2t | ₩86,850.00 | PE14.1x | E35.0% | 0% | Capital Goods | ||
AV1 | AU$0.06 | -1.6% | 39.5% | AU$49.7m | n/a | PS14.6x | E103.9% | n/a | Software | ||
A441270 | ₩7,840.00 | -4.4% | -4.7% | ₩289.9b | ₩11,500.00 | PE18.6x | E36.4% | n/a | Tech | ||
A204620 | ₩3,820.00 | -6.9% | -2.3% | ₩216.9b | ₩7,100.00 | PS2x | E72.4% | n/a | Commercial Services | ||
A179900 | ₩29,700.00 | -1.7% | 53.1% | ₩469.9b | ₩60,000.00 | PS23.4x | E122.7% | 0% | Tech | ||
688408 | CN¥60.86 | -7.8% | 29.9% | CN¥12.0b | CN¥66.22 | PE26.5x | E28.4% | 1.0% | Capital Goods | ||
PLT | AU$0.73 | 0% | 92.1% | AU$126.2m | AU$1.30 | PS1.8x | E106.4% | n/a | Diversified Financials | ||
YGG | ฿1.31 | -1.5% | -82.8% | ฿788.6m | ฿10.75 | PE11.4x | E33.5% | 20.5% | Media | ||
ACI | ₹771.45 | -0.3% | 49.1% | ₹95.2b | ₹788.17 | PE35.3x | E36.0% | 0.4% | Materials | ||
ADOC | €5.63 | -11.6% | -8.5% | €84.7m | €6.30 | PS14x | E63.0% | n/a | Pharmaceuticals & Biotech | ||
505283 | ₹1,283.60 | -5.1% | 108.2% | ₹89.5b | ₹1,706.50 | PE58.5x | E30.1% | 0.5% | Capital Goods | ||
CTT | AU$1.21 | -9.0% | -57.7% | AU$535.4m | AU$3.12 | PE23.8x | E26.7% | n/a | Retail | ||
BCS | NOK 5.40 | 27.4% | -40.0% | NOK 226.6m | NOK 9.00 | PS753x | E50.7% | n/a | Materials | ||
PHC | UK£0.089 | 0.6% | -7.8% | UK£30.3m | n/a | PS3.5x | E121.3% | n/a | Materials |